Retatrutide, a newer triple agonist, may allow biweekly or monthly dosing in some protocols, though most GLP-1s remain weekly
Smooth blending and well-formulated powders create a clean, easy mouthfeel
MNT had the opportunity to speak with Laurie Glasser, MD, a physical medicine and rehabilitation physician at Hackensack Meridian Healths Jersey Shore University Medical Center in New Jersey, as to why GLP-1 use might be linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity
Today, several GLP-1 diabetes medications are indicated for improving blood sugar control in people with Type 2 diabetes (see table above)
How long does it take to see a change